GC Cell Corp — SEC Form 4 filings

SEC reporting owner CIK 1931891. 2 Form 4 filings on record with FilingPulse; latest filed 2026-05-28.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2024-07-22 to 2026-05-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Artiva Biotherapeutics, Inc. (ARTV)10% owner24 legs · 3,515,623 sh · $41,499,97610

Form 4 filings — GC Cell Corp

FiledFormIssuerReported transactionsSource
2026-05-284Artiva Biotherapeutics, Inc. (ARTV)
jointly with GC Corp.
Purchase (P): 1,085,069 @ $11.52 · Purchase (P): 347,222 @ $11.52EDGAR
2024-07-224Artiva Biotherapeutics, Inc. (ARTV)
jointly with GC Corp.
Conversion (C): 667,185 · Conversion (C): 330,095 · Other (J): 294,117 @ $10.20 · Purchase (P): 1,666,666 @ $12 · Conversion (C): 292,791 · Conversion (C): 62,181 · +6 moreEDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1931891 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →